X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23985) 23985
Book Review (4429) 4429
Publication (2491) 2491
Book Chapter (262) 262
Book / eBook (161) 161
Newsletter (133) 133
Conference Proceeding (84) 84
Magazine Article (28) 28
Web Resource (11) 11
Newspaper Article (9) 9
Dissertation (6) 6
Reference (6) 6
Trade Publication Article (4) 4
Transcript (2) 2
Data Set (1) 1
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22250) 22250
humans (16032) 16032
animals (12859) 12859
mice (7143) 7143
female (5480) 5480
proteins (5325) 5325
male (4453) 4453
immunology (4225) 4225
recombinant fusion proteins - therapeutic use (4058) 4058
recombinant fusion proteins - genetics (4010) 4010
biotechnology & applied microbiology (3746) 3746
biochemistry & molecular biology (3484) 3484
recombinant fusion proteins - metabolism (3321) 3321
expression (3016) 3016
recombinant proteins (2829) 2829
gene expression (2653) 2653
analysis (2588) 2588
medicine, research & experimental (2562) 2562
research (2548) 2548
molecular sequence data (2392) 2392
amino acid sequence (2363) 2363
oncology (2347) 2347
cancer (2334) 2334
health aspects (2284) 2284
recombinant proteins - genetics (2193) 2193
recombinant (2117) 2117
recombinant fusion proteins - immunology (2100) 2100
pharmacology & pharmacy (1999) 1999
research article (1929) 1929
biotechnology (1925) 1925
antibodies (1895) 1895
recombinant proteins - metabolism (1894) 1894
cell line (1877) 1877
in-vivo (1852) 1852
cell biology (1842) 1842
middle aged (1841) 1841
adult (1754) 1754
multidisciplinary sciences (1743) 1743
mice, inbred balb c (1742) 1742
medicine (1728) 1728
cell line, tumor (1705) 1705
cells (1702) 1702
article (1683) 1683
vaccines (1650) 1650
rats (1635) 1635
peptides (1614) 1614
recombinant fusion proteins - pharmacology (1609) 1609
antigens (1598) 1598
antibodies, monoclonal - therapeutic use (1590) 1590
recombinant fusion proteins - chemistry (1587) 1587
escherichia-coli (1580) 1580
protein binding (1560) 1560
immunotherapy (1559) 1559
physiological aspects (1539) 1539
microbiology (1523) 1523
protein (1496) 1496
treatment outcome (1494) 1494
hematology (1396) 1396
mice, inbred c57bl (1376) 1376
science (1366) 1366
therapy (1347) 1347
recombinant proteins - therapeutic use (1334) 1334
care and treatment (1331) 1331
recombinant proteins - chemistry (1304) 1304
aged (1298) 1298
biochemical research methods (1288) 1288
escherichia coli - genetics (1287) 1287
recombinant fusion proteins - administration & dosage (1287) 1287
fusion protein (1271) 1271
apoptosis (1258) 1258
transfection (1252) 1252
escherichia coli (1249) 1249
biology (1239) 1239
genetic vectors (1235) 1235
cells, cultured (1232) 1232
genetic aspects (1230) 1230
abridged index medicus (1214) 1214
disease models, animal (1201) 1201
enzymes (1187) 1187
cloning, molecular (1173) 1173
enzyme-linked immunosorbent assay (1147) 1147
base sequence (1137) 1137
recombinant proteins - immunology (1099) 1099
immunization (1086) 1086
recombinant proteins - biosynthesis (1085) 1085
genetic engineering (1082) 1082
binding (1069) 1069
biochemistry (1062) 1062
in-vitro (1056) 1056
recombinant fusion proteins - biosynthesis (1053) 1053
life sciences (1034) 1034
viruses (1034) 1034
genes (1024) 1024
monoclonal antibodies (997) 997
purification (989) 989
gene therapy (968) 968
cloning (964) 964
t cells (937) 937
studies (936) 936
mutation (933) 933
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (92) 92
UofT at Mississauga - Stacks (30) 30
UofT at Scarborough - Stacks (22) 22
Engineering & Comp. Sci. - Stacks (16) 16
Online Resources - Online (16) 16
UTL at Downsview - May be requested (13) 13
St. Michael's College (John M. Kelly) - 2nd Floor (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Robarts - Stacks (6) 6
Law (Bora Laskin) - Stacks (5) 5
St. Augustine's Seminary - Stacks (5) 5
Earth Sciences (Noranda) - Stacks (2) 2
Regis College - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Gerstein Science - Searching (1) 1
OISE - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Not Returned (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24148) 24148
Chinese (70) 70
French (68) 68
Japanese (49) 49
Spanish (48) 48
German (33) 33
Italian (12) 12
Danish (11) 11
Russian (9) 9
Polish (8) 8
Finnish (3) 3
Hungarian (3) 3
Czech (2) 2
Dutch (2) 2
Swedish (2) 2
Croatian (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2013, Volume 369, Issue 24, pp. 2313 - 2323
Journal Article
Blood, ISSN 0006-4971, 06/2014, Volume 123, Issue 25, pp. 3855 - 3863
Journal Article
Science, ISSN 0036-8075, 4/2011, Volume 332, Issue 6028, pp. 478 - 484
The growth factor progranulin (PGRN) has been implicated in embryonic development, tissue repair, tumorigenesis, and inflammation, but its receptors remain... 
Cartilage | Immunization | Antiinflammatories | Medical treatment | REPORTS | Collagens | Antibodies | Bones | Arthritis | Mice | Inflammation | TUMOR-NECROSIS-FACTOR | GENE | MULTIDISCIPLINARY SCIENCES | HOST-DEFENSE | DEGRADATION | OLIGOMERIC MATRIX PROTEIN | GRANULIN-EPITHELIN PRECURSOR | ADAMTS-7 | MUTATIONS | TRANSCRIPTION FACTOR | PSEUDOACHONDROPLASIA | Recombinant Proteins - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Arthritis, Experimental - drug therapy | Recombinant Fusion Proteins - pharmacology | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Intercellular Signaling Peptides and Proteins - chemistry | Male | Receptors, Tumor Necrosis Factor, Type I - metabolism | Recombinant Fusion Proteins - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | T-Lymphocytes, Regulatory - immunology | Arthritis, Experimental - pathology | Young Adult | Intercellular Signaling Peptides and Proteins - metabolism | Cartilage, Articular - metabolism | Receptors, Tumor Necrosis Factor, Type II - metabolism | Adult | Female | Protein Interaction Domains and Motifs | Anti-Inflammatory Agents, Non-Steroidal - metabolism | T-Lymphocytes, Regulatory - physiology | Arthritis, Experimental - physiopathology | Signal Transduction | Intercellular Signaling Peptides and Proteins - genetics | Mice, Transgenic | Arthritis, Experimental - immunology | Mice, Inbred Strains | Receptors, Tumor Necrosis Factor, Type I - genetics | Receptors, Tumor Necrosis Factor, Type II - genetics | Mice, Knockout | Cartilage, Articular - pathology | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Adolescent | Ligands | Aged | Intercellular Signaling Peptides and Proteins - therapeutic use | Care and treatment | Genetic aspects | Properties | Tumor necrosis factor | Growth factors | Index Medicus | Binding | Pathology | Receptors | Pathogenesis
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, pp. CD007419 - CD007419
Background Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti-vascular endothelial growth factor... 
CLINICAL-TRIAL | RANIBIZUMAB PLUS PROMPT | RANDOMIZED CONTROLLED-TRIAL | Receptors, Vascular Endothelial Growth Factor [therapeutic use] | DEFERRED LASER | MEDICINE, GENERAL & INTERNAL | PEGAPTANIB SODIUM | Bevacizumab [adverse effects; therapeutic use] | Laser Coagulation [methods] | Aptamers, Nucleotide [adverse effects; therapeutic use] | Network Meta-Analysis | QUALITY-OF-LIFE | Macular Edema [drug therapy; etiology; surgery] | Vascular Endothelial Growth Factor A [antagonists & inhibitors] | Visual Acuity [drug effects; physiology] | COST-EFFECTIVENESS | Angiogenesis Inhibitors [adverse effects; therapeutic use] | LASER PHOTOCOAGULATION | Randomized Controlled Trials as Topic | Ranibizumab [adverse effects; therapeutic use] | Recombinant Fusion Proteins [adverse effects; therapeutic use] | Quality of Life | INTRAVITREAL BEVACIZUMAB | Diabetic Retinopathy [complications] | Triamcinolone [adverse effects; therapeutic use] | VEGF TRAP-EYE | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - adverse effects | Bevacizumab - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Ranibizumab - adverse effects | Visual Acuity - drug effects | Triamcinolone - adverse effects | Laser Coagulation - methods | Angiogenesis Inhibitors - therapeutic use | Angiogenesis Inhibitors - adverse effects | Triamcinolone - therapeutic use | Visual Acuity - physiology | Aptamers, Nucleotide - therapeutic use | Aptamers, Nucleotide - adverse effects | Macular Edema - surgery | Macular Edema - drug therapy | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2012, Volume 119, Issue 13, pp. 3031 - 3037
Journal Article
Journal Article
Journal Article
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 12, pp. 2537 - 2548
Journal Article
BLOOD, ISSN 0006-4971, 03/2012, Volume 119, Issue 13, pp. 3024 - 3030
Journal Article